Abstract
Background: Cardiotoxicity restricts anthracycline and trastuzumab treatment of Human Epidermal Growth Factor Receptor 2 positive early breast cancer.......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
